{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:42:55Z","timestamp":1791142975145,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.encep.2013.10.007","type":"journal-article","created":{"date-parts":[[2014,2,8]],"date-time":"2014-02-08T01:00:21Z","timestamp":1391821221000},"page":"330-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Traitement du trouble bipolaire en phase maniaque\u00a0: synth\u00e8se critique des recommandations internationales"],"prefix":"10.1016","volume":"40","author":[{"given":"P.A.","family":"Geoffroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bellivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2013.10.007_bib0005","series-title":"The global burden of disease. A comprehensive assessment of morbidity and disability from diseases, injuries and risk factors in 1990\u00a0and projected to 2020","author":"Murray","year":"1996"},{"issue":"4","key":"10.1016\/j.encep.2013.10.007_bib0010","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jphysparis.2013.03.006","article-title":"Reconsideration of bipolar disorder as a developmental disorder: importance of the time of onset","volume":"107","author":"Geoffroy","year":"2013","journal-title":"J Physiol Paris"},{"issue":"Suppl. 3","key":"10.1016\/j.encep.2013.10.007_bib0015","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1016\/S0013-7006(11)70048-3","article-title":"Consequences of delayed diagnosis of bipolar disorders","volume":"37","author":"Scott","year":"2011","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2013.10.007_bib0020","series-title":"Bipolar disorder","author":"NICE","year":"2006"},{"issue":"3","key":"10.1016\/j.encep.2013.10.007_bib0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord"},{"issue":"2","key":"10.1016\/j.encep.2013.10.007_bib0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009\u00a0on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2013.10.007_bib0035","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second edition\u2013recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"J Psychopharmacol (Oxford)"},{"issue":"439","key":"10.1016\/j.encep.2013.10.007_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0447.2009.01383.x","article-title":"Clinical practice recommendations for bipolar disorder","author":"Malhi","year":"2009","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"Suppl. 4","key":"10.1016\/j.encep.2013.10.007_bib0045","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","author":"American Psychiatric Association","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2013.10.007_bib0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/15622970309167904","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: treatment of mania","volume":"4","author":"Grunze","year":"2003","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2013.10.007_bib0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/15622970410029924","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment","volume":"5","author":"Grunze","year":"2004","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2013.10.007_bib0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881103017002003","article-title":"Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology","volume":"17","author":"Goodwin","year":"2003","journal-title":"J Psychopharmacol"},{"issue":"Suppl. 4","key":"10.1016\/j.encep.2013.10.007_bib0065","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S0013-7006(10)70037-3","article-title":"[Screening and management of bipolar disorders: results]","volume":"36","author":"Llorca","year":"2010","journal-title":"Enc\u00e9phale"},{"issue":"Suppl. 3","key":"10.1016\/j.encep.2013.10.007_bib0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-5618.2005.00219.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies","volume":"7","author":"Yatham","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.encep.2013.10.007_bib0075","first-page":"1","article-title":"Troubles Bipolaires","volume":"AL23","author":"HAS","year":"2009","journal-title":"Guide M\u00e9decin"},{"issue":"6","key":"10.1016\/j.encep.2013.10.007_bib0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MLR.0b013e318040ad90","article-title":"Factors that affect adherence to bipolar disorder treatments: a stated-preference approach","volume":"45","author":"Johnson","year":"2007","journal-title":"Med Care"},{"issue":"2","key":"10.1016\/j.encep.2013.10.007_bib0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.163.2.217","article-title":"Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"163","author":"Perlis","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2013.10.007_bib0090","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1176\/appi.ajp.2007.05081484","article-title":"The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD","volume":"165","author":"Schneck","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"9817","key":"10.1016\/j.encep.2013.10.007_bib0095","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.encep.2013.10.007_bib0100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1474-4422(12)70103-5","article-title":"Teratogenic effects of antiepileptic drugs","volume":"11","author":"Tomson","year":"2012","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.encep.2013.10.007_bib0105","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","article-title":"A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"10.1016\/j.encep.2013.10.007_bib0110","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/cns.12017","article-title":"Combination therapy for manic phases: a critical review of a common practice","volume":"18","author":"Geoffroy","year":"2012","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"10.1016\/j.encep.2013.10.007_bib0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jad.2011.10.015","article-title":"New treatment guidelines for acute bipolar mania: a critical review","volume":"140","author":"Nivoli","year":"2012","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.encep.2013.10.007_bib0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1399-5618.2001.30401.x","article-title":"Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines","volume":"3","author":"Lim","year":"2001","journal-title":"Bipolar Disord"},{"issue":"1\u20133","key":"10.1016\/j.encep.2013.10.007_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2006.08.017","article-title":"Pharmacological treatment of acute mania in psychiatric in-patients between 1994\u00a0and 2004","volume":"99","author":"Wolfsperger","year":"2007","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.encep.2013.10.007_bib0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.euroneuro.2010.08.001","article-title":"2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery","volume":"21","author":"Haro","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"issue":"Suppl. 41","key":"10.1016\/j.encep.2013.10.007_bib0135","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1192\/bjp.178.41.s148","article-title":"Use of antipsychotic drugs and lithium in mania","volume":"178","author":"Cookson","year":"2001","journal-title":"Br J Psychiatry"},{"issue":"6","key":"10.1016\/j.encep.2013.10.007_bib0140","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1399-5618.2007.00468.x","article-title":"Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials","volume":"9","author":"Smith","year":"2007","journal-title":"Bipolar Disord"},{"issue":"4","key":"10.1016\/j.encep.2013.10.007_bib0145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0165-0327(80)90029-4","article-title":"A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania","volume":"2","author":"Garfinkel","year":"1980","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.encep.2013.10.007_bib0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archpsyc.1984.01790130061009","article-title":"Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study","volume":"41","author":"Klein","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.encep.2013.10.007_bib0155","series-title":"Anticonvulsants in affective disorders","first-page":"134","article-title":"Carbamazepine and oxcarbazepine in the treatment of manic syndromes: studies in Germany","author":"Muller","year":"1984"},{"key":"10.1016\/j.encep.2013.10.007_bib0160","series-title":"Carbamazepine hastens therapeutic action of lithium in mania. Proceedings international conference on new directions in affective disorders","first-page":"97","author":"Desai","year":"1987"},{"issue":"1\u20132","key":"10.1016\/j.encep.2013.10.007_bib0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0278-5846(89)90009-2","article-title":"Double-blind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol","volume":"13","author":"M\u00f6ller","year":"1989","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.encep.2013.10.007_bib0170","series-title":"Abstract book on 3rd international conference on bipolar disorder (p. 23). Pittsburgh, PA","article-title":"Lamotrigine treatment of lithium failure outpatient mania: a double-blind, placebo-controlled trial","author":"Anand","year":"1999"},{"issue":"2","key":"10.1016\/j.encep.2013.10.007_bib0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00004714-200004000-00012","article-title":"Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study","volume":"20","author":"M\u00fcller-Oerlinghausen","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"3\u00a0Pt 2","key":"10.1016\/j.encep.2013.10.007_bib0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1034\/j.1399-5618.2000.20305.x","article-title":"Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy","volume":"2","author":"Pande","year":"2000","journal-title":"Bipolar Disord"},{"issue":"7","key":"10.1016\/j.encep.2013.10.007_bib0185","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2013.10.007_bib0190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","article-title":"Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy","volume":"59","author":"Tohen","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"10.1016\/j.encep.2013.10.007_bib0195","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/00004583-200210000-00011","article-title":"A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania","volume":"41","author":"Delbello","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.encep.2013.10.007_bib0200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1192\/bjp.182.2.141","article-title":"Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial","volume":"182","author":"Yatham","year":"2003","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2013.10.007_bib0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","article-title":"Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study","volume":"6","author":"Sachs","year":"2004","journal-title":"Bipolar Disord"},{"issue":"Suppl. 1","key":"10.1016\/j.encep.2013.10.007_bib0210","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jad.2007.02.007","article-title":"Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms","volume":"100","author":"McIntyre","year":"2007","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.encep.2013.10.007_bib0215","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/YIC.0b013e328080ca57","article-title":"A double-blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania","volume":"22","author":"Yatham","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"issue":"10","key":"10.1016\/j.encep.2013.10.007_bib0220","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy: a placebo-controlled study","volume":"165","author":"Vieta","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2013.10.007_bib0225","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pnpbp.2008.10.012","article-title":"Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial","volume":"33","author":"Juruena","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2013.10.007_bib0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JCP.0b013e31823f872f","article-title":"Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension","volume":"32","author":"Szegedi","year":"2012","journal-title":"J Clin Psychopharmacol"},{"issue":"5\u00a0Pt 1","key":"10.1016\/j.encep.2013.10.007_bib0235","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-5618.2006.00363.x","article-title":"Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial","volume":"8","author":"Akhondzadeh","year":"2006","journal-title":"Bipolar Disord"},{"issue":"Suppl. 1","key":"10.1016\/j.encep.2013.10.007_bib0240","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jad.2007.02.008","article-title":"Rates of remission\/euthymia with quetiapine in combination with lithium\/divalproex for the treatment of acute mania","volume":"100","author":"Sussman","year":"2007","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.encep.2013.10.007_bib0245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1192\/bjp.bp.107.041301","article-title":"Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes","volume":"192","author":"Tohen","year":"2008","journal-title":"Br J Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.encep.2013.10.007_bib0250","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jad.2010.08.015","article-title":"Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania","volume":"129","author":"Amrollahi","year":"2011","journal-title":"J Affect Disord"},{"issue":"1\u20133","key":"10.1016\/j.encep.2013.10.007_bib0255","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jad.2010.09.011","article-title":"Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study","volume":"129","author":"Berwaerts","year":"2011","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.encep.2013.10.007_bib0260","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/13651501.2011.644564","article-title":"Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania","volume":"16","author":"Ouyang","year":"2012","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"7","key":"10.1016\/j.encep.2013.10.007_bib0265","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.amp.2012.07.005","article-title":"Une entit\u00e9 clinique aux implications th\u00e9rapeutiques majeures\u00a0: le trouble bipolaire \u00e0 d\u00e9but pr\u00e9coce","volume":"170","author":"Geoffroy","year":"2012","journal-title":"Ann Med Psychol (Paris)"},{"issue":"11","key":"10.1016\/j.encep.2013.10.007_bib0270","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1176\/appi.ajp.2009.09030342","article-title":"Enhancing multiyear guideline concordance for bipolar disorder through collaborative care","volume":"166","author":"Bauer","year":"2009","journal-title":"Am J Psychiatry"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700613002509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700613002509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T19:59:29Z","timestamp":1538855969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700613002509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0013700613002509"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2013.10.007","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement du trouble bipolaire en phase maniaque\u00a0: synth\u00e8se critique des recommandations internationales","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2013.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 L\u2019Enc\u00e9phale, Paris. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}